These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 7719116
1. Determination of epidermal proliferative activity in experimental mouse tail test by AgNOR analysis. Heinisch G, Wozel G. Exp Toxicol Pathol; 1995 Jan; 47(1):19-23. PubMed ID: 7719116 [Abstract] [Full Text] [Related]
2. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Vail DM, Kisseberth WC, Obradovich JE, Moore FM, London CA, MacEwen EG, Ritter MA. Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231 [Abstract] [Full Text] [Related]
3. [Nucleolus organizer regions in pathomorphologic tumor diagnosis]. Rüschoff J. Veroff Pathol; 1992 Jun; 139():1-144. PubMed ID: 1413987 [Abstract] [Full Text] [Related]
4. [Use of the AgNOR method for the differential diagnosis of tumors and for the quantification of non-neoplastic epidermal hyperproliferation in dermatohistology]. Heinisch G, Barth J. Zentralbl Pathol; 1994 Mar; 140(1):95-101. PubMed ID: 7515680 [Abstract] [Full Text] [Related]
5. Modified silver staining of nucleolar organizer regions to improve the accuracy of image analysis. Orrea SC, Tomasi VH, Schwint AE, Itoiz ME. Biotech Histochem; 2001 Mar; 76(2):67-73. PubMed ID: 11440307 [Abstract] [Full Text] [Related]
6. An improved system for quantifying AgNOR and PCNA in canine tumors. Hung LC, Pong VF, Cheng CR, Wong FI, Chu RM. Anticancer Res; 2000 Mar; 20(5A):3273-80. PubMed ID: 11062753 [Abstract] [Full Text] [Related]
13. Nucleolar organizer regions in human esophageal disorders: comparison with proliferating cell nuclear antigen by immunostaining. Miyazaki S, Sasano H, Suzuki T, Sawai T, Nishihira T, Mori S. Mod Pathol; 1992 Jul; 5(4):396-401. PubMed ID: 1353881 [Abstract] [Full Text] [Related]
14. [Significance of the AgNOR in tumor pathology]. Pich A, Margaria E, Chiusa L. Pathologica; 2002 Feb; 94(1):2-9. PubMed ID: 11912874 [Abstract] [Full Text] [Related]
15. [AgNOR analysis of astrocytoma in childhood]. Haberland C, Martin H, Guski H, Hufnagl P, Vogel S. Zentralbl Neurochir; 1996 Feb; 57(1):5-11. PubMed ID: 8900893 [Abstract] [Full Text] [Related]
16. [Silver-stained Nucleolar Organizer Regions (AgNOR)]. Derenzini M, Trerè D. Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299 [Abstract] [Full Text] [Related]
19. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours. Yu CC, Fletcher CD, Newman PL, Goodlad JR, Burton JC, Levison DA. J Pathol; 1992 Feb; 166(2):147-52. PubMed ID: 1348532 [Abstract] [Full Text] [Related]
20. The prognostic role of proliferation activity in human CNS tumours: the determination of AgNOR, PCNA and Ki-67 expression. Part 1: AgNOR expression in CNS tumours. Janczukowicz J. Folia Neuropathol; 2003 Feb; 41(2):97-101. PubMed ID: 12899202 [Abstract] [Full Text] [Related] Page: [Next] [New Search]